Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS

Item Type:Article
Title:Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
Creators Name:Krönke, J., Fink, E.C., Hollenbach, P.W., MacBeth, K.J., Hurst, S.N., Udeshi, N.D., Chamberlain, P.P., Mani, D.R., Man, H.W., Gandhi, A.K., Svinkina, T., Schneider, R.K., McConkey, M., Järås, M., Griffiths, E., Wetzler, M., Bullinger, L., Cathers, B.E., Carr, S.A., Chopra, R. and Ebert, B.L.
Abstract:Lenalidomide is a highly effective treatment for myelodysplastic syndrome (MDS) with deletion of chromosome 5q (del(5q)). Here, we demonstrate that lenalidomide induces the ubiquitination of casein kinase 1A1 (CK1α) by the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4(CRBN)), resulting in CK1α degradation. CK1α is encoded by a gene within the common deleted region for del(5q) MDS and haploinsufficient expression sensitizes cells to lenalidomide therapy, providing a mechanistic basis for the therapeutic window of lenalidomide in del(5q) MDS. We found that mouse cells are resistant to lenalidomide but that changing a single amino acid in mouse Crbn to the corresponding human residue enables lenalidomide-dependent degradation of CK1α. We further demonstrate that minor side chain modifications in thalidomide and a novel analogue, CC-122, can modulate the spectrum of substrates targeted by CRL4(CRBN). These findings have implications for the clinical activity of lenalidomide and related compounds, and demonstrate the therapeutic potential of novel modulators of E3 ubiquitin ligases.
Keywords:Amino Acid Sequence, Casein Kinase I, Cell Line, Gene Expression Regulation, HEK293 Cells, Immunologic Factors, Jurkat Cells, K562 Cells, Lenalidomide, Molecular Sequence Data, Myelodysplastic Syndromes, Peptide Hydrolases, Proteolysis, Sequence Alignment, Sequence Deletion, Species Specificity, Thalidomide, Ubiquitin-Protein Ligases, Ubiquitination, Animals, Mice
Source:Nature
ISSN:0028-0836
Publisher:Nature Publishing Group
Volume:523
Number:7559
Page Range:183-188
Date:9 July 2015
Additional Information:Copyright © 2015 Macmillan Publishers Limited. All rights reserved
Official Publication:https://doi.org/10.1038/nature14610
External Fulltext:View full text on PubMed Central
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library